From the Department of Medicine, Division of Physical Medicine and Rehabilitation, University of Toronto, Toronto, Canada (JL, DK); and Toronto Rehabilitation Institute, University Health Network, Toronto, Canada (SMA).
All correspondence should be addressed to: Dinesh Kumbhare, MD, PhD, FRCPC, FAAPMR, Toronto Rehabilitation Institute, Suite 7-131, 550 University Avenue, Toronto, Ontario, Canada M5G 2A2.
Source article: Anderson DR, Dunbar M, Murnaghan J, et al. Aspirin or rivaroxaban for VTE prophylaxis after hip or knee arthroplasty. N Engl J Med. 2018;378(8):699–707.
Financial disclosure statements have been obtained, and no conflicts of interest have been reported by the authors or by any individuals in control of the content of this article.